Add BrightSurf on Google Email

Risk of thrombotic events should not exclude transgender people from receiving hormone therapy, according to new guidance

Research suggests that withholding gender-affirming hormone therapy from transgender individuals may have negative mental and physical effects. A new study provides comprehensive guidance for assessing, managing, and treating venous thromboembolism in transgender patients receiving feminizing hormone therapy.

SourceMassachusetts General Hospital·JournalEndocrine Practice·TypeSystematic review·DateMar 6, 2023

Dutch healthcare system isn't prepared for pregnant transgender men

A recent study by Amsterdam University Medical Center found that transgender men face significant barriers in accessing maternity care due to a lack of understanding and guidance from healthcare providers. The research highlights the need for gender-inclusive care and guidelines to support pregnant transgender men, addressing their uni...

SourceAmsterdam University Medical Center·JournalMidwifery·TypeObservational study·DateMar 1, 2023

Transgender youth, teens more likely to have sleep disorders

A Michigan Medicine-led study reveals that transgender youth are 5.4 times more likely to experience insomnia and three times more likely to suffer from sleep apnea compared to cisgender youth. Gender-affirming therapies may offer a protective effect against worsening sleep health, according to the researchers.

SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Sleep Medicine·TypeObservational study·DateNov 21, 2022

THE LANCET CHILD & ADOL. HEALTH: Study suggests discontinuation of gender-affirming hormones in those who start treatment as adolescents is rare

A study of over 700 adolescents who underwent puberty suppression and then started gender-affirming hormone treatment found that 98% continued use. The findings contradict recent concerns about regret and support the long-term benefits of hormone therapy for young people with gender dysphoria.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·TypeObservational study·DateOct 20, 2022